ClinicalTrials.Veeva

Menu

A Study of a Novel Scheimpflug Device in Diagnosing Keratoconus

T

Tianjin Eye Hospital

Status

Active, not recruiting

Conditions

Keratoconus
Corvis ST
Scansys
Pentacam
Subclinical Keratoconus

Treatments

Other: Pentacam, Corvis ST and Scansys

Study type

Observational

Funder types

Other

Identifiers

NCT06119321
KY2023026

Details and patient eligibility

About

Comparison of the screening and diagnosis ability of the novel Scheimpflug-based tomography device (Scansys) with Pentacam and the Scheimpflug-based biomechanics device (Corvis ST) for keratoconus.

Enrollment

200 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Best corrected visual acuity (BCVA) ≥ 20/20;
  • No other eye diseases except myopia and astigmatism;
  • The cornea was transparent, and there was no cloud or pannus;

Exclusion criteria

  • The presence of ocular diseases other than myopia and keratoconus;
  • Ocular trauma;
  • Previous ocular surgery;
  • Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination;
  • Pregnant and lactating women;

Trial design

200 participants in 3 patient groups

Normal control group
Treatment:
Other: Pentacam, Corvis ST and Scansys
Subclinical keratoconus
Treatment:
Other: Pentacam, Corvis ST and Scansys
Keratoconus
Treatment:
Other: Pentacam, Corvis ST and Scansys

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems